M&A Deal Summary

Bio-Techne Acquires Novus Biologicals

On July 2, 2014, Bio-Techne acquired life science company Novus Biologicals from Mainsail Partners for 60M USD

Acquisition Highlights
  • This is Bio-Techne’s 1st transaction in the Life Science sector.
  • This is Bio-Techne’s 7th largest (disclosed) transaction.
  • This is Bio-Techne’s 2nd transaction in the United States.
  • This is Bio-Techne’s 1st transaction in Colorado.

M&A Deal Summary
Date 2014-07-02
Target Novus Biologicals
Sector Life Science
Buyer(s) Bio-Techne
Sellers(s) Mainsail Partners
Deal Type Add-on Acquisition
Deal Value 60M USD

Target

Novus Biologicals

Littleton, Colorado, United States
Novus Biologicals LLC, is an e-commerce and life sciences company that develops, licenses and markets research materials to scientists in academic, corporate and government laboratories. Since 1996, Novus Biologicals has partnered with scientific researchers and third-party providers to develop a portfolio of more than 100,000 products. These research tools provide investigators with high-quality antibodies, proteins, kits and RNAi for the study of protein functions in disease in the key fields of cancer, neuroscience, and metabolic disorders.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bio-Techne

Minneapolis, Minnesota, United States
Category Company
Founded 1976
Sector Life Science
Employees3,200
Revenue 1.1B USD (2023)
DESCRIPTION
Bio-Techne's corporate headquarters in Minneapolis, Minnesota.
Bio-Techne's corporate headquarters in Minneapolis, Minnesota.

Bio-Techne is a life sciences company that provides bioactive tools and resources for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. Bio-Techne was founded in 1976 and is based in Minneapolis, Minnesota.

DEAL STATS #
Overall 2 of 18
Sector (Life Science) 1 of 11
Type (Add-on Acquisition) 2 of 17
State (Colorado) 1 of 1
Country (United States) 2 of 15
Year (2014) 1 of 3
Size (of disclosed) 7 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-07-22 Bionostics

Devens, Massachusetts, United States

Bionostics, Inc. developer and manufacturer of quality controls for healthcare diagnostic equipments.

Buy $104M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-08-01 ProteinSimple

Santa Clara, California, United States

ProteinSimple develops instrumentation systems, software and assay products that drive discoveries in fields ranging from fundamental protein research to biomarker discovery and personalized medicine.

Buy $300M

Seller(S) 1

SELLER

Mainsail Partners

San Francisco, California, United States

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 2003
PE ASSETS 750M USD
Size Middle-Market
Type Sector Focused
DESCRIPTION

Mainsail Partners is a private equity firm that principally targets investments in North American bootstrapped software companies with proven business models and long-term growth potential. Mainsail looks commit $10 to $75 million of equity capital per transaction in businesses generating annual revenues of $4 to $25 million. Mainsail Partners was formed in 2003 and is based in San Francisco.

DEAL STATS #
Overall 6 of 26
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 4 of 18
State (Colorado) 1 of 1
Country (United States) 6 of 26
Year (2014) 1 of 2
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-07-01 Zego

San Diego, California, United States

Zego is a payments technology and resident engagement platform for the residential real estate industry that unifies critical resident touchpoints into one app. The Company’s mobile-first platform delivers portfolio-wide efficiency, higher NOI and more engaged residents by seamlessly integrating payment, billing and utility expense management capabilities with a proprietary resident engagement and communication portal. Zego also provides smart home device functionality. Zego serves 6,000 residential real estate companies and over 12 million units nationwide. Zego was founded in 2003 and is based in San Diego, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-07-08 Path Logic

Carmichael, California, United States

Path Logic is a provider of specialized anatomic pathology services to Hospitals and physicians in Northern California.

Sell $6M
Mergr

Product

Company

Legal